Oncogenic

PTBP1 SLC2A11–MIF bladder cancer fusion protein mRNA stability metastasis

Journal

MedComm
ISSN: 2688-2663
Titre abrégé: MedComm (2020)
Pays: China
ID NLM: 101769925

Informations de publication

Date de publication:
Sep 2024
Historique:
received: 20 12 2023
revised: 03 07 2024
accepted: 14 07 2024
medline: 19 8 2024
pubmed: 19 8 2024
entrez: 19 8 2024
Statut: epublish

Résumé

Chimeric RNAs, distinct from DNA gene fusions, have emerged as promising therapeutic targets with diverse functions in cancer treatment. However, the functional significance and therapeutic potential of most chimeric RNAs remain unclear. Here we identify a novel fusion transcript of solute carrier family 2-member 11 (

Identifiants

pubmed: 39156764
doi: 10.1002/mco2.685
pii: MCO2685
pmc: PMC11324686
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e685

Informations de copyright

© 2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Liang Cheng (L)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.

Chenwei Yang (C)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.

Junlin Lu (J)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.

Ming Huang (M)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.
Guangdong Provincial Clinical Research Center for Urological Diseases Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.

Ruihui Xie (R)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.
Guangdong Provincial Clinical Research Center for Urological Diseases Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.

Sarah Lynch (S)

Department of Pathology School of Medicine University of Virginia Charlottesville Virginia USA.

Justin Elfman (J)

Department of Pathology School of Medicine University of Virginia Charlottesville Virginia USA.

Yuhang Huang (Y)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.

Sen Liu (S)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.

Siting Chen (S)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.

Baoqing He (B)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.

Tianxin Lin (T)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.
Guangdong Provincial Clinical Research Center for Urological Diseases Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.

Hui Li (H)

Department of Pathology School of Medicine University of Virginia Charlottesville Virginia USA.

Xu Chen (X)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.
Guangdong Provincial Clinical Research Center for Urological Diseases Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.

Jian Huang (J)

Department of Urology Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-Sen University Guangzhou Guangdong China.
Guangdong Provincial Clinical Research Center for Urological Diseases Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong China.

Classifications MeSH